This was reinforced by our studies in the EC-Bmpr2-/- mice where targeted expression of Foxf1 using an AAV vector engineered to be delivered to lung EC prevented persistent pulmonary hypertension during reoxygenation after hypoxia. The gene discussed is BMPR2; the disease is pulmonary arterial hypertension.